Finance

Beta
Lists
ASPN:NYSE
Aspen Aerogels Inc
$5.64
-9.47%
(-0.59) 1D
$5.49
-2.66% (-0.15)
After hours
Closed: Jun 5, 4:00:11 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for ASPN...
Open
$6.16
High
$6.17
Low
$5.54
Mkt. cap
467.43M
Avg. vol.
1.86M
Volume
1.27M
52-wk high
$9.78
52-wk low
$2.30
EPS
-$1.36
Beta
3.03
Shares outstanding
82.88M
No. of employees
854
Open
$6.16
High
$6.17
Low
$5.54
Mkt. cap
467.43M
Avg. vol.
1.86M
Volume
1.27M
52-wk high
$9.78
52-wk low
$2.30
EPS
-$1.36
Beta
3.03
Shares outstanding
82.88M
No. of employees
854
Analyst outlook
Analyst Ratings
Based on 3 analysts giving stock ratings to ASPN in the past 3 months
Buy
Buy
2
Hold
0
Sell
1
12 month forecast
Based on 3 Wall Street analysts offering 12 month price targets for ASPN in the last 3 months.
Highest
Current $5.64
$8.00 (+41.84%)
Average
$5.92 (+4.96%)
Lowest
$4.00 (-29.08%)
News stories
From sources across the web
About Aspen Aerogels Inc
CEODonald R. Young
Employees854
Founded2001
HeadquartersNorthborough, Massachusetts, United States
SectorSpeciality chemicals
Last report
May 7, 2026
Fiscal period
Q1 2026
EPS / Est. (USD)
-$0.28 / -$0.26
-8.74%miss
Revenue / Est. (USD)
37.88M / 36.66M
+3.35%beat
Fiscal Q1 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
78.02M
73.02M
41.34M
37.88M
Cost of goods sold
52.01M
52.22M
42.17M
33.61M
Cost of revenue
52.01M
52.22M
42.17M
33.61M
Research and development expenses
3.79M
2.49M
2.80M
2.72M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
20.78M
20.08M
21.69M
21.96M
Operating expense
24.58M
22.58M
24.48M
24.68M
Total operating expenses
76.59M
74.80M
66.65M
58.29M
Operating income
1.44M
-1.78M
-25.31M
-20.41M
Other non operating income
-
581.00K
75.00K
41.00K
EBT including unusual items
-8.24M
-5.74M
-73.01M
-23.94M
EBT excluding unusual items
-1.64M
-4.17M
-27.94M
-23.52M
Income tax expense
821.00K
594.00K
-97.00K
-253.00K
Effective tax rate
-9.97%
-10.35%
0.13%
1.06%
Other operating expenses
-
-
-
-
Net income
-9.06M
-6.33M
-72.91M
-23.69M
Net profit margin
-11.61%
-8.67%
-176.38%
-62.54%
Earnings per share
-0.04
-0.06
-0.34
-0.28
Interest and investment income
-
-
-
-
Interest expense
-3.08M
-2.97M
-2.70M
-3.15M
Net interest expenses
-3.08M
-2.97M
-2.70M
-3.15M
Depreciation and amortization charges
-
-
-
-
EBITDA
7.23M
3.61M
-19.34M
-15.02M
Gain or loss from assets sale
-
-
18.16M
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more

Research

AI content may include mistakes. Learn more